ARCHIVES

NCI Names 15 to Director’s Consumer Liaison Group.

This article is from The Cancer Letter archive.

Vol. 31 No. 02 | January 14, 2005

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

Sharfstein To Leave FDA

January 7, 2011

Trials Approved In October

December 28, 2001